
Uvnil D 2.5mg/10mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Levocetirizine (2.5mg) + Phenylephrine (10mg)
Overview Uvnil D 2.5mg/10mg Tablet
Aller-Ease Duo 2.5mg/10mg tablets combine medications to relieve allergy symptoms such as nasal discharge, sneezing, sore throat, eye watering, and nasal congestion. Dosage and duration for Aller-Ease Duo 2.5mg/10mg tablets should follow your doctor's instructions, varying based on individual response and condition severity. Continue the prescribed course; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects include headache, dry mouth, nausea, vomiting, agitation, and fatigue, most resolving spontaneously. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until effects are known. Alcohol consumption should be avoided due to potential drowsiness intensification. Self-medication and sharing medication are strongly discouraged. Adequate hydration is recommended. Inform your physician of any liver or kidney conditions before commencing treatment to ensure appropriate dosage. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Uvnil D 2.5mg/10mg Tablet
No text provided to rephrase.
Uses of Uvnil D 2.5mg/10mg Tablet
Allergic rhinitis manifesting as nasal discharge and sneezing.
Major Benefits of Uvnil D 2.5mg/10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Uvnil D 2.5mg/10mg Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Uvnil D 2.5mg/10mg Tablet:
- Headache
- Dryness in mouth
- Nausea
- Vomiting
- Tiredness
- Sleepiness
- Restlessness
How to use Uvnil D 2.5mg/10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Uvnil D 2.5mg/10mg Tablet whole; do not chew, crush, or divide it. This medication can be administered with or without food, although consistent timing is recommended.
How Uvnil D 2.5mg/10mg Tablet works:
Levocetirizine and Phenylephrine, combined as Uvnil D 2.5mg/10mg tablets, offer relief from allergic sneezing and rhinorrhea.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Uvnil D 2.5mg/10mg tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Using Uvnil D 2.5mg/10mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Maternal use of Uvnil D 2.5mg/10mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Uvnil D 2.5mg/10mg tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Uvnil D 2.5mg/10mg tablets cautiously, potentially requiring a modified dosage. Medical advice is necessary. Uvnil D 2.5mg/10mg tablets are contraindicated for individuals with severely compromised kidney function.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Uvnil D 2.5mg/10mg tablets, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Uvnil D 2.5mg/10mg Tablet :
Should you forget to take your Uvnil D 2.5mg/10mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Uvnil D 2.5mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
